Literature DB >> 1991854

No evidence for serological autoimmunity to islet cell heat shock proteins in insulin dependent diabetes.

M A Atkinson1, L A Holmes, D W Scharp, P E Lacy, N K Maclaren.   

Abstract

Recent studies in nonobese diabetic mice have implicated the autoimmune destruction of pancreatic islet cells with immunity to a beta cell protein cross-reactive to Mycobacterium tuberculosis heat shock protein 65 (hsp 65). Therefore, our studies examined serological immunity to islet cell hsp in humans with insulin-dependent diabetes (IDD). Heat shock of human islet cells in vitro markedly increased the synthesis of proteins of 72,000, 75,000, and 90,000 Mr. No autoantibodies reactive to these hsp, nor to the constituently expressed islet cell hsp 65 protein (identified as 60,000 Mr) were observed in IDD patients. The islet cell 64,000-Mr autoantigen and hsp 65 proteins were physiologically and immunocompetitively distinct. These experiments do not support the hypothesis that IDD in humans is associated with autoimmunity to islet cell heat shock proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991854      PMCID: PMC296364          DOI: 10.1172/JCI115051

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

Review 1.  What causes diabetes?

Authors:  M A Atkinson; N K Maclaren
Journal:  Sci Am       Date:  1990-07       Impact factor: 2.142

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Type I diabetes mellitus. A chronic autoimmune disease.

Authors:  G S Eisenbarth
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

4.  Automated method for isolation of human pancreatic islets.

Authors:  C Ricordi; P E Lacy; E H Finke; B J Olack; D W Scharp
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

5.  The Mycobacterium tuberculosis 65-kilodalton antigen is a heat shock protein which corresponds to common antigen and to the Escherichia coli GroEL protein.

Authors:  T M Shinnick; M H Vodkin; J C Williams
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

6.  Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-Mr islet antigen.

Authors:  M A Atkinson; N K Maclaren
Journal:  Diabetes       Date:  1988-11       Impact factor: 9.461

7.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.

Authors:  S Baekkeskov; H J Aanstoot; S Christgau; A Reetz; M Solimena; M Cascalho; F Folli; H Richter-Olesen; P De Camilli; P D Camilli
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

8.  Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins.

Authors:  S Baekkeskov; J H Nielsen; B Marner; T Bilde; J Ludvigsson; A Lernmark
Journal:  Nature       Date:  1982-07-08       Impact factor: 49.962

9.  Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat.

Authors:  S Baekkeskov; T Dyrberg; A Lernmark
Journal:  Science       Date:  1984-06-22       Impact factor: 47.728

10.  64,000 Mr autoantibodies as predictors of insulin-dependent diabetes.

Authors:  M A Atkinson; N K Maclaren; D W Scharp; P E Lacy; W J Riley
Journal:  Lancet       Date:  1990-06-09       Impact factor: 79.321

View more
  11 in total

1.  Inducing immune tolerance: a focus on Type 1 diabetes mellitus.

Authors:  Dan Xu; Suchitra Prasad; Stephen D Miller
Journal:  Diabetes Manag (Lond)       Date:  2013-09-01

2.  An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: human and macaque sequences, tissue distribution, unique and shared epitopes, and predictive autoantibodies.

Authors:  J LaGasse; L Jelinek; S Sexson; C Lofton-Day; J Breininger; P Sheppard; W Kindsvogel; W A Hagopian
Journal:  Mol Med       Date:  1997-03       Impact factor: 6.354

Review 3.  Pharmacological approaches to the prevention of autoimmune diabetes.

Authors:  W E Winter; D V House; D Schatz
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 4.  Islet cell autoantigens in insulin-dependent diabetes.

Authors:  M A Atkinson; N K Maclaren
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 5.  GAD, diabetes, and Stiff-Man syndrome: some progress and more questions.

Authors:  M Solimena; M H Butler; P De Camilli
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

Review 6.  The humoral immune response to heat shock proteins.

Authors:  J Mollenhauer; A Schulmeister
Journal:  Experientia       Date:  1992-07-15

Review 7.  Heat shock proteins in autoimmune disease. From causative antigen to specific therapy?

Authors:  X D Yang; U Feige
Journal:  Experientia       Date:  1992-07-15

Review 8.  Immunotherapy of type 1 diabetes: where are we and where should we be going?

Authors:  Xunrong Luo; Kevan C Herold; Stephen D Miller
Journal:  Immunity       Date:  2010-04-23       Impact factor: 31.745

9.  Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.

Authors:  M R Christie; J A Hollands; T J Brown; B K Michelsen; T L Delovitch
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 10.  Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

Authors:  Brett Phillips; Massimo Trucco; Nick Giannoukakis
Journal:  Clin Dev Immunol       Date:  2011-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.